Long non-coding RNA-mediated regulation of glucose homeostasis and diabetes

American Journal of Cardiovascular Disease

Volumn 6, Issue 2, 2016, Pages 17-25

  Sun, Xinghui ^a   Wong, Danny ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Glucose; Long non coding RNAs

Indexed keywords

GLUCOSE; LONG UNTRANSLATED RNA; MICRORNA; PROTEIN; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

CELL VIABILITY; CHROMATIN; DIABETES MELLITUS; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEART INFARCTION; HUMAN; LUNG ADENOCARCINOMA; METASTASIS; NONHUMAN; PATHOGENESIS; PLASMACYTOMA; REVIEW; RNA STABILITY; TRANSLATION REGULATION;

EID: 85050577734     PISSN: None     EISSN: 2160200X     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Bonnefond A and Froguel P. Rare and common genetic events in type 2 diabetes: what should biologists know? Cell Metab 2015; 21: 357-368.
2. Ezkurdia I, Juan D, Rodriguez JM, Frankish A, Diekhans M, Harrow J, Vazquez J, Valencia A and Tress ML. Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes. Hum Mol Genet 2014; 23: 5866-5878.
3. Hangauer MJ, Vaughn IW and McManus MT. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet 2013; 9: e1003569.
4. Kumar V, Westra HJ, Karjalainen J, Zhernakova DV, Esko T, Hrdlickova B, Almeida R, Zhernakova A, Reinmaa E, Vosa U, Hofker MH, Fehrmann RS, Fu J, Withoff S, Metspalu A, Franke L and Wijmenga C. Human disease-associated genetic variation impacts large intergenic non-coding RNA expression. PLoS Genet 2013; 9: e1003201.
5. Chen G, Qiu C, Zhang Q, Liu B and Cui Q. Genome-wide analysis of human SNPs at long intergenic noncoding RNAs. Hum Mutat 2013; 34: 338-344.
6. Pennisi E. Shining a light on the genome’s ‘dark matter’. Science 2010; 330: 1614.
7. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS and Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009; 106: 9362-9367.
8. Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A, Cao X, Dhanasekaran SM, Wu YM, Robinson DR, Beer DG, Feng FY, Iyer HK and Chinnaiyan AM. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet 2015; 47: 199-208.
9. Rinn JL and Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012; 81: 145-166.
10. Ulitsky I and Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell 2013; 154: 26-46.
11. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A and Rinn JL. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011; 25: 1915-1927.
12. Pauli A, Valen E, Lin MF, Garber M, Vastenhouw NL, Levin JZ, Fan L, Sandelin A, Rinn JL, Regev A and Schier AF. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res 2012; 22: 577-591.
13. Guttman M, Garber M, Levin JZ, Donaghey J, Robinson J, Adiconis X, Fan L, Koziol MJ, Gnirke A, Nusbaum C, Rinn JL, Lander ES and Regev A. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol 2010; 28: 503-510.
14. Ulitsky I, Shkumatava A, Jan CH, Sive H and Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 2011; 147: 1537-1550.
15. Kelley D and Rinn J. Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome Biol 2012; 13: R107.
16. Batista PJ and Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell 2013; 152: 1298-1307.
17. Johnsson P, Lipovich L, Grander D and Morris KV. Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta 2014; 1840: 1063-1071.
18. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, Ruan Y, Lassmann T, Carninci P, Brown JB, Lipovich L, Gonzalez JM, Thomas M, Davis CA, Shiekhattar R, Gingeras TR, Hubbard TJ, Notredame C, Harrow J and Guigo R. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012; 22: 1775-1789.
19. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, Guigo R and Shiekhattar R. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010; 143: 46-58.
20. Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, Blobel GA and Shiekhattar R. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 2013; 494: 497-501.
21. Kim TK, Hemberg M and Gray JM. Enhancer RNAs: a class of long noncoding RNAs synthesized at enhancers. Cold Spring Harb Perspect Biol 2015; 7: a018622.
22. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL and Lander ES. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458: 223-227.
23. Wapinski O and Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21: 354-361.
24. Guil S, Soler M, Portela A, Carrere J, Fonalleras E, Gomez A, Villanueva A and Esteller M. Intronic RNAs mediate EZH2 regulation of epigenetic targets. Nat Struct Mol Biol 2012; 19: 664-670.
25. Faghihi MA and Wahlestedt C. Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 2009; 10: 637-643.
26. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, Suzuki H, Carninci P, Hayashizaki Y, Wells C, Frith M, Ravasi T, Pang KC, Hallinan J, Mattick J, Hume DA, Lipovich L, Batalov S, Engstrom PG, Mizuno Y, Faghihi MA, Sandelin A, Chalk AM, Mottagui-Tabar S, Liang Z, Lenhard B and Wahlestedt C. Antisense transcription in the mammalian transcriptome. Science 2005; 309: 1564-1566.
27. He Y, Vogelstein B, Velculescu VE, Papado-poulos N and Kinzler KW. The antisense transcriptomes of human cells. Science 2008; 322: 1855-1857.
28. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311-1323.
29. Wang X, Arai S, Song X, Reichart D, Du K, Pascual G, Tempst P, Rosenfeld MG, Glass CK and Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008; 454: 126-130.
30. Zhao XY, Li S, Wang GX, Yu Q and Lin JD. A long noncoding RNA transcriptional regulatory circuit drives thermogenic adipocyte differentiation. Mol Cell 2014; 55: 372-382.
31. Gong C and Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3’ UTRs via Alu elements. Nature 2011; 470: 284-288.
32. Pachnis V, Belayew A and Tilghman SM. Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci U S A 1984; 81: 5523-5527.
33. Brannan CI, Dees EC, Ingram RS and Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990; 10: 28-36.
34. Bartolomei MS, Zemel S and Tilghman SM. Parental imprinting of the mouse H19 gene. Nature 1991; 351: 153-155.
35. Gabory A, Jammes H and Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 2010; 32: 473-480.
36. Monnier P, Martinet C, Pontis J, Stancheva I, Ait-Si-Ali S and Dandolo L. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proc Natl Acad Sci U S A 2013; 110: 20693-20698.
37. Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L, Smits G and Reik W. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 2012; 14: 659-665.
38. Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 2013; 333: 213-221.
39. Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ, Lee HY, Yang L, Mueller M, Zhou XB, Dandolo L, Szendroedi J, Roden M, Flannery C, Taylor H, Carmichael GG, Shulman GI and Huang Y. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res 2014; 42: 13799-13811.
40. Zhou J, Yang L, Zhong T, Mueller M, Men Y, Zhang N, Xie J, Giang K, Chung H, Sun X, Lu L, Carmichael GG, Taylor HS and Huang Y. H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase. Nat Commun 2015; 6: 10221.
41. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A and Tilghman SM. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 1995; 375: 34-39.
42. Petry CJ, Evans ML, Wingate DL, Ong KK, Reik W, Constancia M and Dunger DB. Raised late pregnancy glucose concentrations in mice carrying pups with targeted disruption of H19delta13. Diabetes 2010; 59: 282-286.
43. Petry CJ, Seear RV, Wingate DL, Acerini CL, Ong KK, Hughes IA and Dunger DB. Maternally transmitted foetal H19 variants and associations with birth weight. Hum Genet 2011; 130: 663-670.
44. Palatianou ME, Simos YV, Andronikou SK and Kiortsis DN. Long-term metabolic effects of high birth weight: a critical review of the literature. Horm Metab Res 2014; 46: 911-920.
45. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, Lu L, Liu C, Yi JS, Zhang H, Min W, Bennett AM, Gregory RI, Ding Y and Huang Y. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101-112.
46. Hanson RL, Craig DW, Millis MP, Yeatts KA, Kobes S, Pearson JV, Lee AM, Knowler WC, Nelson RG and Wolford JK. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 2007; 56: 975-983.
47. Millis MP, Bowen D, Kingsley C, Watanabe RM and Wolford JK. Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. Diabetes 2007; 56: 3027-3032.
48. Alvarez ML and DiStefano JK. Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy. PLoS One 2011; 6: e18671.
49. Alvarez ML, Khosroheidari M, Eddy E and Kiefer J. Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLoS One 2013; 8: e77468.
50. You L, Wang N, Yin D, Wang L, Jin F, Zhu Y, Yuan Q and De W. Downregulation of Long Noncoding RNA Meg3 Affects Insulin Synthesis and Secretion in Mouse Pancreatic Beta Cells. J Cell Physiol 2015; [Epub ahead of print].
51. Zhu X, Wu YB, Zhou J and Kang DM. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression. Biochem Biophys Res Commun 2016; 469: 319-325.
52. Wallace C, Smyth DJ, Maisuria-Armer M, Walker NM, Todd JA and Clayton DG. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet 2010; 42: 68-71.
53. Zhou L, Xu DY, Sha WG, Shen L, Lu GY and Yin X. Long non-coding MIAT mediates high glucose-induced renal tubular epithelial injury. Biochem Biophys Res Commun 2015; 468: 726-732.
54. Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, Nakamura Y and Tanaka T. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet 2006; 51: 1087-1099.
55. Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li YJ, Tao ZF, Song YC, Chen Q and Jiang Q. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res 2015; 116: 1143-1156.
56. Awata T, Yamashita H, Kurihara S, Morita-Ohkubo T, Miyashita Y, Katayama S, Mori K, Yoneya S, Kohda M, Okazaki Y, Maruyama T, Shimada A, Yasuda K, Nishida N, Tokunaga K and Koike A. A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA. PLoS One 2014; 9: e111715.
57. Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, Yan B and Jiang Q. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 2014; 5: e1506.
58. Puthanveetil P, Chen S, Feng B, Gautam A and Chakrabarti S. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med 2015; 19: 1418-1425.
59. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ and O’Malley BW. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999; 97: 17-27.
60. Lanz RB, Razani B, Goldberg AD and O’Malley BW. Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). Proc Natl Acad Sci U S A 2002; 99: 16081-16086.
61. Xu B, Gerin I, Miao H, Vu-Phan D, Johnson CN, Xu R, Chen XW, Cawthorn WP, MacDougald OA and Koenig RJ. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS One 2010; 5: e14199.
62. Liu S, Xu R, Gerin I, Cawthorn WP, Macdougald OA, Chen XW, Saltiel AR, Koenig RJ and Xu B. SRA regulates adipogenesis by modulating p38/JNK phosphorylation and stimulating insulin receptor gene expression and downstream signaling. PLoS One 2014; 9: e95416.
63. Liu S, Sheng L, Miao H, Saunders TL, MacDougald OA, Koenig RJ and Xu B. SRA gene knockout protects against diet-induced obesity and improves glucose tolerance. J Biol Chem 2014; 289: 13000-13009.
64. Fadista J, Vikman P, Laakso EO, Mollet IG, Esguerra JL, Taneera J, Storm P, Osmark P, Ladenvall C, Prasad RB, Hansson KB, Finotello F, Uvebrant K, Ofori JK, Di Camillo B, Krus U, Cilio CM, Hansson O, Eliasson L, Rosengren AH, Renstrom E, Wollheim CB and Groop L. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc Natl Acad Sci U S A 2014; 111: 13924-13929.
65. Liu Y, Ferguson JF, Xue C, Ballantyne RL, Silverman IM, Gosai SJ, Serfecz J, Morley MP, Gregory BD, Li M and Reilly MP. Tissue-specific RNA-Seq in human evoked inflammation identifies blood and adipose LincRNA signatures of cardiometabolic diseases. Arterioscler Thromb Vasc Biol 2014; 34: 902-912.
66. Mattick JS and Rinn JL. Discovery and annotation of long noncoding RNAs. Nat Struct Mol Biol 2015; 22: 5-7.
67. Diederichs S. The four dimensions of noncoding RNA conservation. Trends Genet 2014; 30: 121-123.
68. Majewski J and Pastinen T. The study of eQTL variations by RNA-seq: from SNPs to phenotypes. Trends Genet 2011; 27: 72-79.